BORDI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 1.832
EU - Europa 1.804
AS - Asia 815
AF - Africa 34
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.491
Nazione #
US - Stati Uniti d'America 1.796
CN - Cina 601
FI - Finlandia 541
SE - Svezia 360
IE - Irlanda 328
UA - Ucraina 208
DE - Germania 196
SG - Singapore 101
TR - Turchia 90
IT - Italia 89
CA - Canada 35
CI - Costa d'Avorio 33
GB - Regno Unito 33
BE - Belgio 27
IN - India 16
CZ - Repubblica Ceca 6
AT - Austria 4
IR - Iran 4
CL - Cile 3
ES - Italia 3
FR - Francia 3
AU - Australia 2
KR - Corea 2
NL - Olanda 2
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
PA - Panama 1
RO - Romania 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 4.491
Città #
Chandler 337
Dublin 328
Jacksonville 284
Ann Arbor 159
Dearborn 129
Beijing 116
Nanjing 103
Ashburn 91
Izmir 90
Boardman 82
Singapore 65
Princeton 63
Shanghai 60
New York 58
San Mateo 56
Parma 43
Wilmington 37
Shenyang 35
Abidjan 33
Toronto 33
Bremen 32
Helsinki 32
Nanchang 32
Hefei 29
Kunming 29
Brussels 27
Hebei 27
Jinan 25
Des Moines 22
Grafing 22
Los Angeles 19
Tianjin 16
Changsha 12
Santa Clara 12
Guangzhou 11
Woodbridge 9
Munich 8
Zhengzhou 8
Augusta 7
Jiaxing 7
Norwalk 7
Pune 7
Seattle 7
Taiyuan 7
Fuzhou 6
Haikou 6
Milan 6
Mordano 6
Dallas 5
Düsseldorf 5
Auburn Hills 4
Brno 4
Hangzhou 4
Ningbo 4
Chengdu 3
Fremont 3
Houston 3
Lanzhou 3
Leipzig 3
Madrid 3
Magdeburg 3
Reggio Nell'emilia 3
Taizhou 3
Vienna 3
Xian 3
Baotou 2
Belluno 2
Borås 2
Chongqing 2
Clifton 2
Collebeato 2
Marseille 2
Monmouth Junction 2
Prague 2
Sabz 2
Wuhan 2
Ardabil 1
Bari 1
Berlin 1
Birmingham 1
Brisbane 1
Cairo 1
Canberra 1
Changchun 1
Charlotte 1
Dundee 1
Edinburgh 1
Fairfield 1
Fiorano Modenese 1
Fornovo Di Taro 1
Huizen 1
Jinhua 1
Las Vegas 1
Leawood 1
Lissone 1
London 1
Madison 1
Mountain View 1
Mumbai 1
New Delhi 1
Totale 2.745
Nome #
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 108
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 105
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 104
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 102
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 96
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 93
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion 92
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 91
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 88
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 86
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 86
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 86
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 83
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 82
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 82
Plasma concentration and brain penetration of the H3-receptor antagonist Thioperamide in rats 81
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 79
Action of histamine and ofdifferent synthetic P^ receptor stimulants on the isolated gastric fundus of theguinea pig 78
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 78
HPLC detection ofthioperamide from biological samples and its determination in rat blood and brainafter systemic administration 77
Functional Studies of New Imidazole H3-Antagonists on Guinea-Pig Isolated Preparations 75
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 75
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 74
Effects of antimuscarinic agents, H2-blockers and omeprazole on rat chronic gastric ulcer after long-a and short-term administration 73
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 72
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 72
A possible physiological role ofhistamine H^-receptors in rat mesenteric circulation 71
Hz-agonistiimidazolici: importanza della 2-amino sostituzione per 1'attivita farmacologica 71
Sviluppo e caratterizzazione farmacologica di un nuovo potente e selettivo H3-bloccante istaminico non-tioureico 70
Heteroarylaminoethyl and heteroarylthioethylimidazoles. Synthesis and H3-receptor affinity 70
Structural researcheson H^-agonists: the structures of the dipicrates of 2-(2-amino-4-imidazolyl)ethylamine, its 5-methyl derivative and N^f-dimeihyl-2-(2-am'mo-l,3-thiazol-5-yl)ethylamine 70
H3-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives 70
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 70
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 70
Biological studies on 1,2-benzisothiazole derivatives. V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation 69
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 68
Irreversible EGFR inhibitor compounds with antiproliferative activity 68
Ligands for the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type 66
Pharmacological activities of two new histamine analogs 66
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 66
In vitro characterization of potency, affinity and selectivity of H3-antagonists: from thioperamide to thioperamide unrelated derivatives 66
H3-receptor antagonists: Synthesis and structure relationships of para- and meta-substituted 4(5)-phenyl-2-((2-(4(5)-imidazolyl)ethyl)thio)imidazoles 65
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 65
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 63
Pharmacological profile of original potent H3 receptor antagonists 61
Are histamine receptors involved in the stimulant activities of thiazolylethylamines supposed as cyclic models of dimaprit? 61
null 61
Auxin-like activity of 1,2-benzisothiazole derivatives 59
Studio di sostanze analoghe alDimaprit sulla secrezione gastrica "in vitro" 59
Pharmacological profile of new thioperamide derivatives at histamine peripheral H1-, H2, H3-receptors in guinea-pig 57
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H3-receptor antagonist activity in gastric fistula cat 56
Rat protein binding and cerebral phospholipid affinity of the H3-receptor antagonist thioperamide 55
A possible physiological role of histamine H2-receptors in rat mesenteric circulation 55
Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain 55
Action of histamine and of different synthetic H2 receptor stimulants on the isolated gastric fundus of the guinea pig 54
Antipyretic activity of new compounds "4-(3-OXO-1,2-BENZISOTHIAZOLIN-2-YL) PHENYLALKANOIC acids, their esters, amides and 1,1-dioxide derivatives 54
Synthesis and binding assays of H3-receptor ligands. 53
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 53
QSAR study on H3-receptor affinity of benzothiazole derivatives of thioperamide 50
Melatonin Receptor Ligands: Synthesis of New Melatonin Derivatives and Comprehensive Comparative Molecular Field Analysis (CoMFA) Study. 46
Antipyreticactivity of new compounds 4-(3-oxo-l,2-benzisothiazolin-2-yl)puenyialkanoicacids, their esters, amides and 1,1 dioxide derivatives 38
null 37
Pharmacological activities of two new histamine analogs 33
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H2-receptor antagonist activity in gastric fistula cat. 32
THIAZOLYLALKYLAMINES - SYNTHESIS OF ANALOGS OF IMIDAZOLYLETHYLAMINES AND THEIR INFLUENCE ON GASTRIC-SECRETION 30
Are histamine receptors involved in the stimulant activities ofthiazolylethylamines supposed as cyclic models of dimaprit? 12
Totale 4.513
Categoria #
all - tutte 16.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020597 0 0 0 12 76 95 117 18 122 44 48 65
2020/2021440 8 65 30 9 60 2 59 5 101 8 91 2
2021/2022344 7 3 3 30 17 33 45 49 19 24 21 93
2022/20231.308 156 143 89 86 121 162 18 74 411 10 30 8
2023/2024410 22 45 3 10 31 137 39 17 14 19 27 46
2024/2025226 51 78 89 8 0 0 0 0 0 0 0 0
Totale 4.513